| Literature DB >> 22719738 |
Amy Stroud1, Susan Liddell, Thorsten Allers.
Abstract
Single-stranded DNA (ssDNA)-binding proteins play an essential role in DNA replication and repair. They use oligonucleotide/oligosaccharide-binding (OB)-folds, a five-stranded β-sheet coiled into a closed barrel, to bind to ssDNA thereby protecting and stabilizing the DNA. In eukaryotes the ssDNA-binding protein (SSB) is known as replication protein A (RPA) and consists of three distinct subunits that function as a heterotrimer. The bacterial homolog is termed SSB and functions as a homotetramer. In the archaeon Haloferax volcanii there are three genes encoding homologs of RPA. Two of the rpa genes (rpa1 and rpa3) exist in operons with a novel gene specific to Euryarchaeota; this gene encodes a protein that we have termed RPA-associated protein (rpap). The rpap genes encode proteins belonging to COG3390 group and feature OB-folds, suggesting that they might cooperate with RPA in binding to ssDNA. Our genetic analysis showed that rpa1 and rpa3 deletion mutants have differing phenotypes; only Δrpa3 strains are hypersensitive to DNA damaging agents. Deletion of the rpa3-associated gene rpap3 led to similar levels of DNA damage sensitivity, as did deletion of the rpa3 operon, suggesting that RPA3 and RPAP3 function in the same pathway. Protein pull-downs involving recombinant hexahistidine-tagged RPAs showed that RPA3 co-purifies with RPAP3, and RPA1 co-purifies with RPAP1. This indicates that the RPAs interact only with their respective associated proteins; this was corroborated by the inability to construct rpa1 rpap3 and rpa3 rpap1 double mutants. This is the first report investigating the individual function of the archaeal COG3390 RPA-associated proteins (RPAPs). We have shown genetically and biochemically that the RPAPs interact with their respective RPAs, and have uncovered a novel single-stranded DNA-binding complex that is unique to Euryarchaeota.Entities:
Keywords: COG3390 RPA-associated protein; Cdc48d; DNA repair; Haloferax volcanii; RPA single-strand DNA-binding protein; archaea; protein overexpression
Year: 2012 PMID: 22719738 PMCID: PMC3376784 DOI: 10.3389/fmicb.2012.00224
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Operon and domain structures of . Genes for RPA1 and RPA3 are in operons with genes for RPA-associated proteins, RPAP1 and RPAP3, respectively. The gene for RPA1 phosphoesterase (RPE) is present in the rpa1 operon. Domains (not to scale) comprising OB-folds, zinc fingers and a phosphoesterase motif are shown.
.
| Strain | Relevant genotype | Source or reference |
|---|---|---|
| DS2 | Wild-type | Mullakhanbhai and Larsen ( |
| H195 | Δ | Guy et al. ( |
| H1209 | Δ | Allers et al. ( |
| H1216 | Δ | H195 pTA1170 |
| H1217 | Δ | H195 pTA1166 |
| H1244 | Δ | H195 pTA1174 |
| H1246 | Δ | H195 pTA1189 |
| H1260 | Δ | H195 pTA1207 |
| H1280 | Δ | H1216 pTA1217 |
| H1281 | Δ | H1217 pTA1141 |
| H1282 | Δ | H1246 pTA1207 pop-in |
| H1326 | Δ | H1280 pTA1174 pop-in |
| H1333 | Δ | H1209 pTA1240 |
| H1390 | Δ | H1282 pTA1265 pop-in |
| H1410 | Δ | H195 pTA1284 |
| H1424 | Δ | H1333 pTA1294 |
| H1430 | Δ | H1424 pTA963 |
| H1473 | Δ | H1281 pTA1284 pop-in |
| H1480 | Δ | H1424 pTA1280 |
| H1481 | Δ | H1424 pTA1281 |
| H1482 | Δ | H1424 pTA1326 |
| H1483 | Δ | H1424 pTA1327 |
*Genes shown within <> are present on an episomal plasmid, genes shown within [] are present on an integrated plasmid (pop-in).
Plasmids.
| Plasmid | Relevant properties | Source or reference |
|---|---|---|
| pBluescript II SK+ | Standard cloning vector | Stratagene |
| pTA131 | Integrative vector based on pBluescript II, with | Allers et al. ( |
| pTA409 | Shuttle vector containing ampicillin, | Delmas et al. ( |
| pTA884 | pBluescript II with | This study |
| pTA898 | pBluescript II with | This study |
| pTA937 | pBluescript II with | This study |
| pTA963 | Overexpression vector with 6xHis-tag, | Allers et al. ( |
| pTA1141 | pTA131 containing | This study |
| pTA1142 | pTA131 containing | This study |
| pTA1166 | This study | |
| pTA1170 | Deletion construct of | This study |
| pTA1174 | This study | |
| pTA1180 | pTA131 with | Allers et al. ( |
| pTA1189 | pTA131 with | This study |
| pTA1196 | This study | |
| pTA1207 | Deletion construct of | This study |
| pTA1217 | This study | |
| pTA1218 | pTA963 with | This study |
| pTA1222 | pTA963 with | This study |
| pTA1223 | pTA963 overexpression vector with | This study |
| pTA1224 | pTA963 with | This study |
| pTA1240 | Gene replacement construct with insertion of 896 bp | This study |
| pTA1265 | pTA409 with insertion of | This study |
| pTA1280 | pTA1218 with | This study |
| pTA1281 | pTA1224 with | This study |
| pTA1282 | This study | |
| pTA1284 | This study | |
| pTA1288 | pBluescript II with | This study |
| pTA1294 | pTA131 with 2,247 bp | This study |
| pTA1326 | pTA1222 with | This study |
| pTA1327 | pTA1223 with | This study |
Oligonucleotides.
| Oligonucleotide | Sequence (5′–3′) | Relevant properties | Use (plasmid generated) |
|---|---|---|---|
| Rpa1CF DS | GTTCGAGGTACCGTTCGGGGAGC | Δ | pTA1141 |
| Rpa1CR DS | AGGTGCGCATATGAGCGCCTCGC | Δ | pTA1141 |
| Rpa1 CR US | TACTACGTCTAGACGGACCTGTTCG | Δ | pTA1141 |
| Rpa1 CF US | GGTCGAGTTCCATATGGTCGGGATTCGCC | Δ | pTA1141 |
| Rpa3KpnI F | GCCGGTGGTACCACAGCCTC | Δ | pTA1142 |
| Rpa3NdeIR | GCAAATCAGTCATATGCTACCTCGCC | Δ | pTA1142 |
| Rpa3EcoRIR | GACGGTGGAATTCGGCCGTCG | Δ | pTA1142 |
| Rpa3NdeI FC | GCGAGGTCGATGCATATGAGTTCCAACG | Δ | pTA1142 |
| trpANdeIF | CTCTGCACATATGTCGCTCGAAGACGC | pTA1166 | |
| trpANdeIR | TGCATGCCATATGCGTTATGTGCG | pTA1166 | |
| RPAP11kpnIus | CCGCGAGTGGTACCGCAAGCCCG | Δ | pTA1170 |
| RPAP11nsiIus | CGACGACCGGCGATGCATTCATGCGCGC | Δ | pTA1170 |
| RPAP11sphIds | GCTGAAGGGCATGCGAGGCCGTGC | Δ | pTA1170 |
| RPAP11ecoRIds | CGGCGAGAGAATTCCCTGCCCGGG | Δ | pTA1170 |
| PEecorI F | GCCCGAATTCCGTCTGATTG | Δ | pTA1189 |
| Rpa1CR US | TACTACGTCTAGACGGACCTGTTCG | Δ | pTA1189 |
| RPEndeI R DS | CTACCGGAACATATGACTCGGGTCG | Δ | pTA1189 |
| Rpa1ndeI F2 | GTTGGACCCATATGTCGAACGACG | Δ | pTA1189 |
| RPAP11SphI US | GCGATTTCCCGCATGCCGACGACCG | Δ | pTA1217 |
| RPAP11 kpnI us | CCGCGAGTGGTACCGCAAGCCCG | Δ | pTA1217 |
| Rpa3BspHI F | AGGTAGATCATGACTGATTTGC | pTA1218 | |
| Rpa3 RAsel | CGAGTGGGGAATTCGTTGGAATTAATTTACATC | pTA1218 | |
| Rpa1F | CCCGACTCCATGGAACTCGACC | pTA1222 | |
| Rpa1AseI/ | CGGCGGCGAATTCGCGGTAGGCGATTAATCGCGTGC | pTA1222 | |
| pTA1327 | |||
| RPAP1F | GGTGCGCTCATGAGCGCCTCG | pTA1223 | |
| RPAP1BamHI | CGTTCGGGGGATCCGCGCCTGC | pTA1223 | |
| pTA1326 | |||
| RPAP3BspHI F | GTCGATGTTCATGAGTTCCAACG | pTA1224 | |
| RPAP3EcoRI R | CGGTCGGAATTCAGGCCGAC | pTA1224 | |
| pTA1280 | |||
| HsaCdc48F | GTTCTTGGCATATGACCGAGGCTCTC | Forward primer for | pTA1240, Probe Figure |
| HsaCdc48R | CTGACAGATCTCGCAGTCACAGC | Reverse primer for | pTA1240, Probe Figure |
| Rpa3BstEII | GATGCGCGGTGACCTCGTGG | pTA1280 | |
| Rpa3NdeI | CGAGGTAGCATATGACTGATTTGCG | pTA1281 | |
| RPAP3 gitF | CTCCCAATGGGTACCAAGGTGGAGGC | Δ | pTA1282 |
| RPAP3 gitR | TCGTTGGACATATGTTACATCGACCTCGC | Δ | pTA1282 |
| RPAP3 F DS | CTCGCTGAATTCGGTGGGTGC | Δ | pTA1282 |
| RPAP3 R DS | CTGAGCGCATATGCGGGCGTCTCG | Δ | pTA1282 |
| cdc48dUF | ACGGGTACCCACGTTGCTGG | pTA1294 | |
| cdc48dDR | GCCGAATTCGAGCCGAGGTGG | pTA1294 | |
| cdc48d-CtrR | CGGCGCGCTAGCCGGACCGGTTACGC | Internal reverse primer to generate C-terminally truncated | pTA1294 |
| cdc48d-CtrF | CTGTGGTGCTAGCCGTCGTCCGACCCCG | Internal forward primer to generate C-terminal truncated | pTA1294 |
| cdc48dSeqF | GGAAAAAGGGGCAGATGGTG | Forward primer to downstream flanking region of | PCR Figure |
| cdc48dHvSeqR | CGACGACATCTCGCTGATTCG | Reverse primer to | PCR Figure |
| cdc48dHsalSeqR | GGTCAACACGCTGCTGAAGTCC | Reverse primer to | PCR Figure |
| Rpa1BstEII | CCGGCACGGTGACCGCCATCC | pTA1326 | |
| Rpa1NdeI | CCCGACCATATGGAACTCGACC | pTA1327 |
Identification of proteins present in cellular soluble fraction after purification by affinity chromatography on a Ni.
| Prot accession | Protein name | HVO_# | Predicted MW | Observed MW | MASCOT score | Number of peptides | % coverage | Peptide sequences |
|---|---|---|---|---|---|---|---|---|
| gi[292655491] | RPAP1 | 1337 | 64,829 | 57,781 | 671 | 12 | 18 | 8 |
| gi[292655492] | RPA1 | 1338 | 45,954 | 36,960 | 940 | 15 | 40 | 11 |
| gi[292655491] | RPAP1 | 1337 | 64,829 | 62,780 | 578 | 10 | 21 | 9 |
| gi[292655492] | RPA1 | 1338 | 45,954 | 45,686 | 808 | 15 | 40 | 12 |
| gi[292654471] | RPAP3 | 0291 | 21,979 | 15,074 | 435 | 10 | 53 | 7 |
| gi[292654471] | RPAP3 | 0291 | 21,979 | 16,217 | 484 | 10 | 59 | 8 |
| gi[292654472] | RPA3 | 0292 | 34,562 | 28,262 | 796 | 13 | 43 | 10 |
| gi[292654472] | RPA3 | 0292 | 34,562 | 31,741 | 735 | 13 | 48 | 11 |
| gi[292656508] | Hypothetical protein | 2381 | 52,319 | 55,300/50,200 | 240 | 5 | 11 | 5 |
| gi[292493992] | Hypothetical protein | B0053 | 13,897 | 4,73,600 | 259 | 4 | 33 | 3 |
| gi[292656425] | Deoxyhypusine synthase | 2297 | 38,616 | 39,500 | 451 | 7 | 25 | 4 |
| gi[292655899] | Thioredoxin reductase | 1758 | 36,505 | 38,000 | 312 | 6 | 21 | 6 |
| gi[292493992] | Hypothetical protein | B0053 | 13,897 | 36,300 | 208 | 6 | 40 | 4 |
| gi[292656748] | Htr-like protein | 2629 | 30,266 | 31,700 | 93 | 4 | 17 | 4 |
| gi[292654704] | Ferritin | 0536 | 19,892 | 24,900 | 66 | 1 | 6 | 1 |
| gi[292653937] | Transcriptional regulator | A0388 | 20,201 | 22,300 | 586 | 15 | 54 | 8 |
| gi[292493992] | Hypothetical protein | B0053 | 13,897 | 13,500 | 170 | 3 | 33 | 3 |
Prot Accession, the database entry, e.g., gi|292655491; predicted MW, predicted molecular weight (Da) of the protein sequence identified by MASCOT; observed MW, molecular weight estimated from migration on SDS-PAGE; MASCOT score, MASCOT score associated with protein identification; number of peptides, no. of peptides associated with protein identification by MASCOT; % coverage, % of the database sequence entry that is covered by the peptides matched to it in the MASCOT data. Peptide sequences, the number of distinct peptide sequences associated with the protein identified by MASCOT.
Figure 2(A) Map of rpa1 operon indicating location of Δrpa1, Δrpap1, and Δrpa1 operon deletions, as well as the BspEI and NruI sites, and probes used to verify the deletions. (B) Southern blot of genomic DNA cut with BspEI and probed with flanking regions of rpa1 and rpap1, as shown in (A), to indicate deletion of rpa1 and rpap1, respectively. (C) Southern blot of genomic DNA cut with NruI and probed with flanking regions of rpa1 operon (rpa1 op.), as shown in (A), to indicate deletion of the rpa1 operon.
Figure 3(A) Map of rpa3 operon indicating location of Δrpa3, Δrpap3, and Δrpa3 operon deletions, as well as the AscI, MluI, StuI, and XhoI sites and probes used to verify the deletions. (B) Southern blot of genomic DNA cut with StuI and XhoI, and probed with flanking regions of rpa3, as shown in Figure 2A, to indicate deletion of rpa3. (C) Southern blot of genomic DNA cut with AscI and StuI, and probed with flanking regions of rpap3, as shown in Figure 2A, to indicate deletion of the rpap3. (D) Southern blot of genomic DNA cut with MluI and probed with flanking regions of rpa3 operon (rpa3 op.), as shown in Figure 2A, to indicate deletion of the rpa3 operon.
Figure 4(A) Wild-type (WT), rpa1, rpap1, rpa1 operon, rpa3, rpap3, rpa3 operon (H195, H1217, H1216, H1246, H1244, H1410, and H1260, respectively), were plated out and exposed to ultraviolet (UV) radiation. The average and standard error (SE) of three experiments are shown. (B) The strains shown in (A) were plated out and exposed to mitomycin C (MMC). The average and SE of three experiments are shown.
Figure A1(A) Map of rpa3 operon indicating location of Δrpa3, Δrpap3, and Δrpa3 operon deletions, as well as the AscI and StuI sites and the probe used to verify the deletions. The size of this fragment in the wild-type (H195) is 8 kb. (B) Southern blot of genomic DNA cut with AscI and StuI, and probed with flanking regions of rpa3 operon (rpa3 op.), as shown in (A), indicates failure to generate Δrpa1 Δrpap3 mutant as bands of the expected size for deletion are not seen (3.4 and 4.4 kb). (C) Southern blot of genomic DNA cut with AscI and StuI, and probed with flanking regions of rpa3 op., as shown in (A), indicates failure to generate Δrpap1 Δrpa3 mutant as bands of the expected size for deletion are not seen (2.8 and 5 kb). (D) Southern blot of genomic DNA cut with AscI and StuI, and probed with flanking regions of rpa3 op., as shown in (A) indicates failure to generate Δrpa1 operon Δrpa3 operon mutant as bands of the expected size for deletion are not seen (2.8 and 3.4 kb).
Figure 5(A) Protein sequence alignment of C-terminus of Cdc48d from selected species of haloarchaea (Hvo, H. volcanii; Hsa, Halobacterium salinarum; Hma, Haloarcula marismortui; Hwa, Haloquadratum walsbyi; Hla, Halorubrum lacusprofundi; Nph, N. pharaonis; Hvo-Ct, H. volcanii C-terminal truncation Cdc48d-Ct). Histidine residues are indicated by a black background. (B) Colony hybridization of 5-FOA-resistant clones of H. volcanii H1333, after pop-in/pop-out gene replacement with pTA1294. H. salinarum cdc48d sequences (Hsa-cdc48d) were used as a probe, clones failing to hybridize therefore carry the truncated H. volcanii cdc48d-Ct allele present in pTA1294. (C) Verification of truncated cdc48d-Ct allele in H1424 by PCR (488 bp product), with primers specific to either H. volcanii or H. salinarum genes. H1209 genomic DNA was used as a control for wild-type H. volcanii cdc48d (563 bp product), and H1333 was used as a control for H. salinarum cdc48d (560 bp product). (D) H. volcanii strains H1209 and H1424 containing empty vector pTA963 (Allers et al., 2010) were used in mock protein overexpression. Histidine-rich cellular proteins were purified from the soluble fraction (lysate) by affinity chromatography on a Ni2+ chelating column, samples were taken from the flow-through (flow) and bound proteins were eluted using 50 and 500 mM imidazole. Precipitation using trichloroacetic acid and deoxycholate was used to enhance visualization and identification of the eluted proteins by mass spectrometry. Cdc48d (HVO_1907) eluted from cell extracts of H1209 but not from H1424 (cdc48d-Ct).
Figure 6. The histidine-tagged recombinant proteins were purified from the soluble fraction (lysate) by affinity chromatography on a Ni2+ chelating column, samples were taken from the flow-through (FT) and bound proteins were eluted using 50 and 500 mM imidazole. Precipitation using trichloroacetic acid and deoxycholate was used to enhance visualization and identification of the eluted proteins by mass spectrometry. Stars denote contaminants shown in Figure 5D.